156 related articles for article (PubMed ID: 34368097)
1. SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome.
Moisoiu V; Sas V; Stefancu A; Iancu SD; Jurj A; Pasca S; Iluta S; Zimta AA; Tigu AB; Teodorescu P; Turcas C; Blag C; Dima D; Popa G; Arghirescu S; Man S; Colita A; Leopold N; Tomuleasa C
Front Bioeng Biotechnol; 2021; 9():703268. PubMed ID: 34368097
[TBL] [Abstract][Full Text] [Related]
2. SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathy.
Stefancu A; Moisoiu V; Desmirean M; Iancu SD; Tigu AB; Petrushev B; Jurj A; Cozan RG; Budisan L; Fetica B; Roman A; Dobie G; Turcas C; Zdrenghea M; Teodorescu P; Pasca S; Piciu D; Dima D; Bálint Z; Leopold N; Tomuleasa C
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 264():120216. PubMed ID: 34364036
[TBL] [Abstract][Full Text] [Related]
3. SERS assessment of the cancer-specific methylation pattern of genomic DNA: towards the detection of acute myeloid leukemia in patients undergoing hematopoietic stem cell transplantation.
Moisoiu V; Stefancu A; Iancu SD; Moisoiu T; Loga L; Dican L; Alecsa CD; Boros I; Jurj A; Dima D; Bagacean C; Tetean R; Burzo E; Tomuleasa C; Elec F; Leopold N
Anal Bioanal Chem; 2019 Nov; 411(29):7907-7913. PubMed ID: 31745615
[TBL] [Abstract][Full Text] [Related]
4. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome and leukemia: insights into leukemogenesis and translational targets.
Mateos MK; Barbaric D; Byatt SA; Sutton R; Marshall GM
Transl Pediatr; 2015 Apr; 4(2):76-92. PubMed ID: 26835364
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Investigation of DNA Demethylation in Leukemia Cells by Means of Ultrasensitive Vibrational Spectroscopy.
Onaciu A; Toma V; Moldovan C; Țigu AB; Cenariu D; Culic C; Borșa RM; David L; Știufiuc GF; Tetean R; Tomuleasa C; Știufiuc RI
Sensors (Basel); 2022 Dec; 23(1):. PubMed ID: 36616944
[TBL] [Abstract][Full Text] [Related]
7. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K
Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome.
Grimm J; Heckl D; Klusmann JH
Front Oncol; 2021; 11():636633. PubMed ID: 33777792
[TBL] [Abstract][Full Text] [Related]
10. Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.
Malinge S; Chlon T; Doré LC; Ketterling RP; Tallman MS; Paietta E; Gamis AS; Taub JW; Chou ST; Weiss MJ; Crispino JD; Figueroa ME
Blood; 2013 Oct; 122(14):e33-43. PubMed ID: 23980066
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of double-stranded DNA amplified by a polymerase chain reaction employing surface-enhanced Raman spectroscopy.
Dou X; Takama T; Yamaguchi Y; Hirai K; Yamamoto H; Doi S; Ozaki Y
Appl Opt; 1998 Feb; 37(4):759-63. PubMed ID: 18268650
[TBL] [Abstract][Full Text] [Related]
12. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome.
Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R
Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822
[TBL] [Abstract][Full Text] [Related]
14. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
15. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC; Ge Y; Taub JW
J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
[TBL] [Abstract][Full Text] [Related]
17. Analysis of GATA1 mutations and leukemogenesis in newborns with Down syndrome.
Queiroz LB; Lima BD; Mazzeu JF; Camargo R; Córdoba MS; Q Magalhães I; Martins-de-Sá C; Ferrari I
Genet Mol Res; 2013 Oct; 12(4):4630-8. PubMed ID: 24222239
[TBL] [Abstract][Full Text] [Related]
18. Hematological disorders and leukemia in children with Down syndrome.
Bruwier A; Chantrain CF
Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
[TBL] [Abstract][Full Text] [Related]
19. Dissecting stepwise mutational impairment of megakaryopoiesis in a model of Down syndrome-associated leukemia.
Evans EJ; DeGregori J
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35838049
[TBL] [Abstract][Full Text] [Related]
20. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing.
Lim JH; Kang YJ; Lee BY; Han YJ; Chung JH; Kim MY; Kim MH; Kim JW; Cho YH; Ryu HM
Clin Epigenetics; 2019 Dec; 11(1):180. PubMed ID: 31801612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
